Department of Gynecology, Yunnan University of Traditional Chinese Medicine, Kunming 650011, China.
Department of Proctology, China-Japan Friendship Hospital, Beijing 100029, China.
Med Eng Phys. 2022 Sep;107:103866. doi: 10.1016/j.medengphy.2022.103866. Epub 2022 Aug 8.
To systematically investigate the clinical efficacy and prognosis of laparoscopic surgery combined with drug therapy for endometriosis.
Clinical randomized controlled trials regarding laparoscopic surgery combined with drug therapy for endometriosis and published between 2010 and 2022 were retrieved from PubMed, Web of Science and Embase, China National Knowledge Infrastructure, and Wanfang databases. Meta-analysis and sensitivity tests were performed using the Stata16.0 software.
A total of 1332 articles were retrieved. Of them, 11 studies were included for final analysis, comprising of 521 cases in the treatment group (laparoscopic surgery combined with drug therapy) and 530 cases in the control group (laparoscopic surgery alone). Meta-analysis results showed that compared with the control group, the combined treatment had higher treatment effective rate [OR = 4.542, 95% CI (3.062, 6.736), P < 0.001], pregnancy rate [OR = 3.341, 95% CI (2.336, 4.780), P < 0.001], and lower incidence of adverse reactions [OR = 0.348, 95% CI (0.208, 0.583), P < 0.001] and recurrence rate [OR = 0.187, 95% CI (0.106, 0.328), P < 0.001]. In addition, after treatment, estradiol [SMD = -3.417, 95% CI (-4.631, -2.203), P < 0.001] and follicle-stimulating hormone [SMD = -1.976, 95% CI (-3.202, -0.751), P = 0.002] in the treatment group were significantly lower than the control group.
Compared with laparoscopic surgery alone, laparoscopic surgery combined with drug therapy demonstrated better clinical efficacy and improved postoperative infertility and recurrence rate for treating endometriosis.
系统评价腹腔镜手术联合药物治疗子宫内膜异位症的临床疗效及预后。
计算机检索 2010 年至 2022 年期间 Pubmed、Web of Science、Embase、中国知网、万方数据库中关于腹腔镜手术联合药物治疗子宫内膜异位症的临床随机对照试验,采用 Stata16.0 软件进行 Meta 分析和敏感性检验。
共检索到 1332 篇文献,最终纳入 11 项研究,共 521 例治疗组(腹腔镜手术联合药物治疗)和 530 例对照组(单纯腹腔镜手术)。Meta 分析结果显示,与对照组相比,联合治疗的有效率[OR=4.542,95%CI(3.062,6.736),P<0.001]、妊娠率[OR=3.341,95%CI(2.336,4.780),P<0.001]更高,不良反应发生率[OR=0.348,95%CI(0.208,0.583),P<0.001]和复发率[OR=0.187,95%CI(0.106,0.328),P<0.001]更低。此外,治疗后治疗组雌二醇[SMD=-3.417,95%CI(-4.631,-2.203),P<0.001]和卵泡刺激素[SMD=-1.976,95%CI(-3.202,-0.751),P=0.002]均低于对照组。
与单纯腹腔镜手术相比,腹腔镜手术联合药物治疗子宫内膜异位症可提高临床疗效,改善术后不孕及复发率。